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Abstract 
Crystals of the bovine thrombin-hirudinsl_65 complex 
have space group P6122 with cell constants a = 116.4, 
and c = 200.6A and two thrombin molecules in the 
asymmetric unit. Only one thrombin molecule could be 
located by generalized molecular replacement; the 
second was fit visually as a rigid body to an improved 
electron-density difference map. The structure was 
refined to R = 0.192 with two B values per residue 
(main chain and side chain) at 3.2A. The polar 
interactions of the peptides with the exosite of thrombin 
show differences consistent with the known flexibility in 
the interactions of the C-terminal peptide of hirudin 
with thrombin. The hirudin peptide in complex 2 has a 
higher temperature factor as compared with peptide 1 
which may be correlated partly with a larger number of 
short-range lectrostatic nteractions between peptide 1 
and thrombin and partly with the fact that thrombin 2 is 
E-thrombin which is cleaved at Thr149A near the 
peptide binding site. Later, using this structure as a test 
case, it was shown that the position for the second 
thrombin could also be determined by a novel 
modification of the molecular-replacement method in 
which the contribution of the known molecule is 
subtracted from the structure factors. This approach is 
facile and applicable to any crystal containing two or 
more macromolecules in the asymmetric unit in which 
some but not all of the molecules can be determined by 
molecular eplacement. 
I. Introduction 
a-Thrombin (E.C. 3.4.21.4), a trypsin-like serine 
protease that is activated by factor Xa cleavage of 
prothrombin, exhibits both procoagulant and anti- 
coagulant activities in the blood-clotting cascade 
(reviewed by Mann, 1987; Davie, Fujikawa & Kisiel, 
t Current address: Berlex Biosciences, 15049 San Pablo Avenue, 
Richmond, CA 94804, USA. 
1991). Free a-thrombin triggers platelet clotting, 
generates fibrin and active factor XIII to stabilize the 
clot and activates clotting factors V, VIII and XI, 
which in turn generate more o~-thrombin (Fenton, 1986; 
Davie et al., 1991, and references therein). In contrast, 
a-thrombin bound to thrombomodulin decelerates clot- 
ting by preferentially activating protein C, which then 
proteolytically inactivates factors Va and Vil la in the 
clotting cascade leading to thrombin (Esmon, 1987; 
Dittman & Majerus, 1990). Thrombin also triggers the 
inflammation response to vascular damage by activating 
neutrophils and monocytes (reviewed by Coughlin, 
1994). 
Bovine c~-thrombin has an A chain of 49 residues 
linked by a single disulfide bond to a B chain of 259 
residues (Magnusson, Petersen, Sottrup-Jensen & 
Claeys, 1975; MacGillivray & Davie, 1984; Walz, 
Hewett-Emmett & Guillin, 1986) which is glycosylated 
at Asn60G. Human oe-thrombin has 13 fewer residues in 
the A chain because of an additional cleavage during 
activation. The B chain has a classic, trypsin-like active 
site with a catalytic triad comprised of His57,J/Aspl02 
and Ser195 and an acidic residue, Asp189, at the bottom 
of the specificity pocket. In contrast with trypsin, 
however, access to the active site for macromolecular 
substrates is severely restricted in thrombin due to 
insertions of additional residues on either side of the 
active-site groove (Bode et al., 1989). Furthermore, 
thrombin has a unique secondary substrate-binding site, 
called the anion-binding site or exosite, which interacts 
with residues that are, relatively speaking, exception- 
ally far 'downstream' from the cleavage site (Fenton, 
1981). Overall, human and bovine ct-thrombin have 
very similar properties despite nine sequence differ- 
ences in the A chain, and 34 sequence differences in the 
J/The residue numbers for thrombin in this paper are assigned by 
homology with chymotrypsin (Bode et al., 1989). A suffix denotes an 
insertion in the thrombin sequence r lative to that of chymotrypsin. 
Sequence numbers for hirudin are identified by the suffix 'h'. The 
prime symbol (') denotes a residue number in a symmetry-related 
molecule. 
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B chain (Butkowski, Elion, Downing & Mann, 1977; 
Degan, MacGillivray & Davie, 1983; Walz et al., 
1986). 
Hirudin, an extremely potent inhibitor of clotting that 
is secreted by leeches (Markwardt, 1970), binds to 
bovine thrombin with a dissociation constant of 3.0pM 
and to human thrombin with a dissociation constant of 
0.3pM (Dodt, Konler & Baici, 1988; Dodt, Kohler, 
Schmitz & Wilhelm, 1990). It has 65 residues, 
including a sulfated tyrosine at position 63. The solution 
structure of free hirudin determined by NMR methods 
(Clore, Sukumaran, Nilges, Zarbock & Gronenborn, 
1987; Folkers et al., 1989; Haruyama & W0thrich, 
1989) has a compact amino-terminal domain of 49 
residues followed by 16 residues that are disordered. 
Crystal structures of the hirudin complex with bovine 
thrombin (Vitali et al., 1992) and with human thrombin 
(Griitter et al., 1990; Rydel et al., 1990; Rydel, 
Tulinsky, Bode & Huber, 1991) show the amino- 
terminal domain of hirudin sitting across the active site 
while the carboxyl-terminal domain stretches out to the 
exosite in an extended, but generally well defined 
conformation. 
The hirudin carboxyl-terminal peptide either alone 
(Maraganore, Chao, Joseph, Jablonski & Ramachan- 
dran, 1989; DiMaio et al., 1990) or linked to an active- 
site ligand (Maraganore, Bourdon, Jablonski, Rama- 
chandran & Fenton, 1990) has been investigated as a 
synthetic analog of hirudin. Alone, the peptide binds 
only to the exosite where it inhibits fibrinogen binding 
and thus clotting but does not inhibit hydrolysis of small 
synthetic substrates of thrombin at the active site (Di 
Maio et al., 1990; Maraganore t al., 1989). Inhibitors 
containing an active-site ligand linked to a C-terminal 
fragment of hirudin block both the active site and the 
exosite (Bourdon, Jablonski, Chao & Maraganore, 
1991; Yue et al., 1992). Carboxyl-terminal fragments 
of hirudin are more effective inhibitors of human as 
compared to bovine ct-thrombin by an order of 
magnitude (Maraganore t al., 1989; Di Maio et al., 
1990). 
Several structures of complexes of human ct-thrombin 
with inhibitors containing a C-terminal hirudin peptide 
in the exosite have been determined (Banner & 
Hadvary, 1991; Skrzypczak-Jankun et al., 1991; Qiu 
et al., 1992; Stubbs et al., 1992; Maryanoff et al., 
1993; Priestle, Rahuel, Rink, Tones & Grfitter, 1993; 
Zdanov et al., 1993). The thrombin-hirudinsl_6S 
structure reported here differs from previous studies 
by (1) incorporating bovine thrombin, which has a 
lower binding affinity for hirudin instead of human 
thrombin, (2) using a high ionic strength precipitant 
instead polyethylene glycol, and (3) having the hirudin 
peptide complexed with both ct-thrombin and e- 
thrombin in the asymmetric unit. Furthermore, this 
crystal form, in space group P6~22 which is a new space 
group for thrombin structures, was a challenging 
crystallographic problem in which one of the thrombins 
in the asymmetric unit could be located by molecular 
replacement but not the other. While this problem was 
solved using graphics, a facile hardy method that uses 
modified structure factors in the molecular-replacement 
calculations was also developed to solve the 'case of the 
missing molecule' which both we and others have 
encountered multiple times (Zhang & Matthews, 1994). 
The method is general and applicable to any crystal 
containing two or more macromolecules in the asym- 
metric unit in which some but not all of the molecules 
can be determined by molecular eplacement. 
2. Materials and methods 
2.1. Preparation of bovine thrombin and hirudin 51-65 
Thrombin was prepared as previously described 
(Martin, Kumar, Tsernoglou & Edwards, 1983) and 
had approximately 2000 NIH clotting units per mg of 
protein. It was stored at 203 K in ammonium phosphate 
pH 6.5 before being set up for crystallization. Hirudin 
51-65 was synthesized by solid-phase techniques on a 
Boc-Gln-O-resin; following synthesis, removal of the 
protecting roups and cleavage of the peptide from the 
resin, the peptide extracts were lyophilized and purified 
by preparative reverse-phase high-pressure liquid 
chromatography (Johnson et al., 1991). 
2.2. Crystallization 
Bovine ct-thrombin was brought to 295K concen- 
trated to 23.5 mg m1-1 by centrifugation using Centri- 
prep 30 (Amicon) at 3600 rev min -I and exchanged into 
0.25 M ammonium phosphate pH 8.0 using a Sephadex 
G-25 column. The complex with the inhibitor was 
prepared using a molar ratio of 1:3. The crystals were 
grown by the hanging-drop method at 295K from 
reservoirs containing 39% saturated ammonium sulfate, 
0.25M ammonium phosphate pH8.0 and 1% 
PEG 4000. The drops initially contained 5 lal reservoir 
solution and 5 lxl complex solution. The crystals are 
hexagonal, cell constants a - 116.4, c -- 200.6 A, space 
group P6122 with two complexes per asymmetric unit. 
2.3. Data collection 
Intensity data were measured at 295 K on the largest 
crystal (approximate dimensions 0.40 x 0.20 
× 0.20mm) using a Siemens area detector with a 
three-circle goniostat, a Rigaku RU200H rotating- 
anode X-ray source and Supper graphite monochro- 
mator. The Cu Kc~ radiation was generated at 40 kV and 
70 mA. The crystal-to-detector distance was 25 cm and 
the swing angle 20 was 16 °. One 'sweep' only was made 
covering 110 ° in oJ with 440 frames of data. Each frame 
was measured for 10rain to ensure that it contained at 
least 1.5 million total counts. A total ~f 31897 
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measurements with I > 0 were merged, scaled and 
averaged with the XENGEN package (Howard et al., 
1987) to give 11 300 unique reflections (80% complete 
to 3.2 A). The overall, unweighted, absolute Rsy m was  
0.126. The completeness and average I /a of the data for 
shells of increasing resolution were 89% and 14.3 for 
~-5.8,~,  92% and 8.2 for 5.8-4.6,&; 90% and 6.3 
for 4.6-4.0A; 86% and 4.1 for 4.0-3.7A; 82% and 
2.8 for 3.7-3.4,~,; and 41% and 2.0 for 3.4-3.2,~. 
2.4. Structure solution 
The orientation and position of one of the two 
thrombins (thrombin 1) was determined by the general- 
ized molecular-replacement method using X-PLOR 
(Brfinger, 1988, 1990). The probe used in these 
calculations was bovine o~-thrombin in the complex 
with hirudin (Vitali et al., 1992). Residues 1H-1C and 
residue 15 of the A chain, the y-autolysis loop residues 
147-149D and residues 245-247 of the B chain were not 
part of the model. These segments are flexible and are 
likely to differ between the present structure and bovine 
thrombin-hirudin. The real-space Patterson search was 
calculated using data in the resolution range 15.0-4.0,~ 
and a shell of integration 5.0-24.0A. The selected 
peaks of the rotation function were subsequently 
Patterson correlation (PC) refined in 15 steps using 
data 15.0-4.0A. The data used in the translation 
searches were in the resolution range 7.0-4.0,~,, and 
the grid interval was 1.28 ,& along a and b, and 1.20 
along c. All molecular-replacement calculations used 
data with IFI > 4a. 
All efforts to locate thrombin molecule 2 by the 
generalized molecular-replacement method proved 
unsuccessful. However, the C,~ backbone of thrombin 
was fitted as a rigid body by visual inspection of an 
electron-density difference map computed with all 
available data in the resolution range 20.0-3.2,&, and 
with phases (calculated from molecule 1) improved by 
solvent flattening, histogram matching and Sayre's 
equation using SQUASH (Zhang, 1993). This solution 
was confirmed by refinement. 
2.5. Refinement 
The parameters of Engh & Huber (1991) and the 
standard input files of X-PLOR for rigid-body, posi- 
tional, simulated-annealing, and B-factor refinement 
were used. C~, atoms related by non-crystallographic 
symmetry were weakly restrained in their average 
positions throughout the refinement using an effective 
energy constant of 100kcalmol-~Jk -2. In order to 
ensure good geometry, at most stages of the refinement, 
weights equal to half the weight from the checkstage 
were used. At the early stages of the analysis, the 
program GPRLSA (Furey, Wang & Sax, 1982) was 
used for the refinement of the positional and thermal 
parameters. At all stages, the data used in the 
refinement were in the resolution range 7.0-3.2,~, 
with IFI > 2a. All graphics rebuilding of the model 
was carried out with the program TOM/FRODO 
(Cambillau & Horjales, 1987; Jones, 1985). 
2.6. Incorporation of known structural information in 
molecular eplacement 
Four electron-density difference maps were calcu- 
lated with phases from thrombin molecule 1 as follows: 
(I) an unmodified IFo[- IF~I electron-density map, (II) 
an IFol- IFcI electron-density map with figures of merit 
and phases improved by solvent flattening, histogram 
matching and Sayre's equation using SQUASH, (III) a 
2lFol- IF~I electron-density map and (IV) a 21Fol- IF~I 
electron-density map with figures of merit and phases 
improved by solvent flattening, histogram matching, 
and Sayre's equation using SQUASH. The electron 
density within 2.0 A of the atomic positions of thrombin 
1 was then set to zero in maps (III) and (IV) (RHOMOD) 
program; P. Martin, unpublished work). These four 
'thombin-1 subtracted' maps were inverted with pro- 
grams from W. Furey Jr (University of Pittsburgh) to 
generate structure factors which corresponded to the 
uninterpreted regions of the unit cell. The modified 
structure factors (15.0-4.0,~) were used for rotation 
function, PC and translation-function calculations in 
X-PLOR. The rotation function was calculated with a 
5.0-24.0A shell of integration and PC refinement was 
carried out in 15 steps. 
2.7. Structure analysis 
Hydrogen bonds were calculated in QUANTA 
(Biosym/MSI, San Diego, CA, USA) using as criteria 
a distance of 3.5A or less between the donor and 
acceptor atoms and a value of 90 ° or more for the angles 
centered at these atoms. A maximum distance of 4.0 A 
was used for hydrophobic contacts and salt links. 
Coordinate sets 1HRT for bovine thrombin-hirudin 
(Vitali et al., 1992) and 1HAH for human thrombin- 
hirugen* (Skrzypczak-Jankun et al., 1991; Vijay- 
alakshmi, Padmanabhan, Mann & Tulinsky, 1994) from 
the Protein Data Bank (Abola, Bernstein, Bryant, 
Koetzle & Wang, 1987) were used for comparative 
analysis. All overlaps were calculated with the program 
ALIGN (Satow, Cohen, Padlan & Davies, 1986). 
3. Results and discussion 
3.1. Structure solution 
The orientation of thrombin 1 was weakly indicated 
by the rotation function. It corresponded to the top 
selected peak, at (01,02, 03) = (265.0, 65.0, 47.5 °) but 
was only 1.05 times greater than the highest noise peak. 
* Hirugen is hirudin residues 53h-65h sulfated at Tyr63h. 
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After PC refinement, the signal-to-noise ratio of this 
peak substantially improved and its correlation coeffi- 
cient of 0.034 was 1.48 times greater than the highest 
PC value corresponding to an error peak. The top peak 
in the translation search for space group P6122, which 
had a correlation coefficient of 0.306, corresponded to
the position of thrombin 1 in the unit cell at (0.400, 
0.200, 0.452), and was 1.62 times greater than the next 
highest independent peak. The determination of the 
space group was unambiguous. The top peaks in the 
translation searches for space groups P6522, P6222, 
P6422, P6322 and P622, which had correlation 
coefficients of 0.138, 0.116, 0.143, 0.122 and 0.116, 
respectively, were much smaller. Refinement of the 
rigid-body parameters of thrombin 1 with X-PLOR 
followed by refinement of the positional parameters 
with GPRLSA gave a crystallographic R factor of 0.356, 
indicating that the molecular-replacement solution for 
thrombin 1 was correct. 
Residues 154-163, 129C-139, and 196-206, corre- 
sponding to part of one of the two/~-barrels of thrombin 
2, the connecting segments between ,&strands 164-179 
and 97-100, and residues 231-239 containing part of a 
helix of thrombin were recognized in the SQUASH 
electron-density difference map and were used as a 
guide in fitting the C~ backbone of thrombin as a rigid 
body to the density of this map (Fig. 1). Refinement of 
the rigid-body parameters of both thrombins with 
X-PLOR, followed by refinement of their positional 
and thermal parameters with GPRLSA reduced the R 
factor to 0.211, indicating that the graphics olution for 
thrombin 2 was correct. 
3.2. Refinement 
Electron density for residues 56h-60h of peptide 1 
bound to thrombin 1 and for residues 56h and 57h 
of peptide 2 bound to thrombin 2 at positions 
corresponding to those in the bovine and human 
thrombin-hirudin complexes was apparent in the 
21Fo]- ]Fcl electron-density map phased with the two 
thrombin molecules. The remaining residues of both 
peptides had fragmented electron density. Because 
the density for the carboxyl-terminal turn was also 
weak in our bovine thrombin-hirudin complex, the 
human thrombin-hirudin complex was superimposed 
on both thrombin molecules and residues 55h-65h 
from human thrombin-hirudin were included in our 
model for both complexes. After refinement of the 
rigid-body parameters of both peptides, seven cycles 
of positional and B-factor refinement, simulated 
annealing and five further cycles of positional and 
B-factor refinement followed, all alternating with 
manual rebuilding of the model. The final R value 
(a) 
2 
(b) 
Fig. 1. Stereoviews of the electron 
density around Pro198. (a) The 
SQUASH electron-density differ- 
ence map from which thrombin 2 
was determined contoured at 
1.3a. (b) The same view in the 
final 21Fo[- [F~] electron-density 
map contoured at 1.7tr. 
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of the structure is 0.192 with an r.m.s, deviation of 
0.009,~ for bond lengths and 1.88 ° for bond angles. 
Because of the moderate resolution of this analysis, Dmin (,~,)* No. of reflections Rshel 1 
two 'group' B values were used for each residue in 5.40 1264 0.223 
the final model, one for the main-chain atoms and 4.67 1360 0.173 
one for the side-chain atoms. The variation of the R 4.22 1292 0.167 
value as a function of resolution is given in Table 3.91 1192 0.174 
1. The mean error in the coordinates estimated from 3.67 1096 0.178 
3.49 1103 0.216 
SIGMAA is 0.5A (Read, 1986). When analyzed by 3.33 937 0.221 
PROCHECK (Laskowski, MacArthur & Thornton, 3.20 415 0.253 
1994), 96.9% of the residues fell within the allowed 
regions of a Ramachandran plot, 2.1% were in the 
Table 1. Variation of the R value as a function of 
resolution 
* Reflections beyond 7.0 A were not included. 
Rsphere 
0.223 
0.195 
0.185 
0.182 
0.182 
0.186 
0.189 
0.192 
(a) 
~ 175' 
. "~. 
~38 ~ ~ . ~  ~ ~ / ~ 7 4  
(b) 
Fig. 2. Stereoviews of the inter- 
actions of residues Phe56h- 
Glu58h of peptide 1 with throm- 
bin. (a) The final 2IFoI_IF~I 
electron-density within 2.0A of 
peptide 1contoured at1.0a. Thick 
lines are used for bonds in peptide 
1; medium weight lines for bonds 
in thrombin. (b) The skeletal 
representation of the interactions. 
Thick lines are used for bonds in 
peptide 1; thin lines for bonds in 
thrombin. 
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generously allowed regions and 1% were in 
disallowed areas. Other measures of the stereo- 
chemistry, including the standard deviations for the 
09 angles (1.5°), ¢ angles (1.9°), and pooled Xl 
angles (19.5 ° ) are better than the average values for 
other structures at a similar resolution. Peptide 2 
has weaker electron density and higher temperature 
factors (average B = 74,~ 2) as compared to peptide 
1 (average B= 56,~2), even though thrombin 
molecules 1 and 2 have similar average temperature 
factors of 20 and 25,~z. The fit of the refined model 
to the electron density is shown in Figs. 1, 2(a) and 
3(a). 
3.3. The failure of the generalized molecular-replace- 
ment method to determine thrombin 2 
The correct orientation of thrombin 2 has Euler 
angles 110.4, 79.7, and 7.5 ° in the asymmetric unit of 
the rotation function. The 57th selected peak of the 
(a) 
(b) 
,4  57'1 // 
/ 
74 
Fig. 3. Stereoviews of the interac- 
tions of residues Phe56h-Glu57h 
of peptide 2 with thrombin. (a) 
The refined 21Fo[_ [F~I electron 
density within 2.0A of peptide 2 
contoured at 0.90. Thick lines are 
used for bonds in peptide 2; 
medium-weight lines for bonds in 
thrombin. (b) The skeletal repre- 
sentation ofthe interactions. Thick 
lines are used for bonds in peptide 
1; thin lines for bonds in 
thrombin. 
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Table 2. Comparison of the effect of the modifications of 
the structure factors on determining thrombin 2 by 
molecular eplacement 
The calculations reported were carried out using 15.0-4.0.~ data, 
unless stated otherwise, and a 5.0-24.0,~ shell of integration for the 
rotation function. The signal to noise (S/N) is calculated as the peak- 
height ratio of the correct peak to the highest error peak. The deviation 
of an orientation from the correct orientation of thrombin 2 is 
measured by the overall rotation ~ (X-PLOR) that relates the two 
orientations. The Eulerian angles 0 I, 02, 03 are according to the 
convention of Rossmann & Blow (1962), and X, Y, Z are fractional 
coordinates. All angles are in degrees. 
(a) Rotation search 
Modification 01 02 03 ~ Rank SIN 
None 112.5 77.5 0.0 7.7 57 0.94 
(I) 110.0 82.5 5.0 3.8 26 0.89 
(II) 110.0 85.0 7.5 5.3 18 0.91 
(III) 112.5 77.5 5.0 3.7 3 0.98 
(IV) 112.5 77.5 5.0 3.7 1 1.03 
(b) Patterson correlation refinement 
Modification 01 02 03 ~ Rank SIN 
None 114.1 73 .2 -1 .6  11.1 17 0.61 
(I) 110.7 78.9 6.6 1.2 6 0.60 
(II) 110.7 77.7 6.4 2.3 3 0.98 
(III) 110.6 78.4 6.4 1.6 1 1.03 
(IV) 110.9 78.0 6.6 1.9 1 1.14 
(c) Translation search* 
Modification X Y Z Rank S/N 
None Failed 
(I) 0.122 0.456 0.428 1 1.41 
(II) 0.122 0.444 0.416 1 1.29 
(III) 0.122 0.456 0.428 1 1.48 
(IV) 0.122 0.456 0.428 1 1.45 
Correlation 
coefficient 
0.014 
0.014 
0.017 
0.020 
0.022 
Correlation 
coefficient 
0.208 
0.189 
0.270 
0.240 
* The translation search was carried out using 7.0-4.0,~ data 
rotation function had Euler angles of 112.5, 77.5 and 
0.0 ° that were close to the correct orientation. Its ratio 
to the rotation-function value of the top noise peak was 
0.94. After 15 steps of PC refinement, his orientation 
had Euler angles of 114.1, 73.2, -1.6 ° and a 
correlation coefficient of 0.014, which placed it 17th 
in the list of the PC-refined selected peaks. Its ratio to 
the top error peak was only 0.61. The low signal-to- 
noise was the reason that this peak was overlooked 
during structure determination. Moreover, a three- 
dimensional translation search carried out for the 
purpose of this.analysis with this PC refined orientation 
using 7.0-4.0 A data was not successful. Not one of the 
100 top peaks of the translation function corresponded 
to the correct position. Translation searches are very 
sensitive to errors in the orientation and the PC 
refinement moved the molecule further away from the 
correct orientation. The PC-refined angles, (114.1, 
73.2, -- 1.6°), differed by an overall rotation (3) of 11.1 ° 
from the correct orientation. The corresponding figure 
for the rotation-function angles was 7.7 ° . When the 
calculations were repeated with 8.0-5.0A data and a 
5.0-24.0 ,~ shell of integration for the rotation function, 
the closest orientation to the correct solution ranked 
29th in the rotation function and at the top but equal to 
the highest noise peak after PC refinement. It did not 
give the correct position in the top 100 peaks of the 
translation function. 
Even when starting with the accurately oriented 
search model, PC refinement moves thrombin 2 away 
from the correct orientation. After ten steps of PC 
refinement, he refined angles deviate from the correct 
orientation by rotations of 4.6 ° for 15.0-4.0 ,~ data and 
6.5 ° for 8.0-5.0A data. The sensitivity of the 
translation function to the accuracy of the orientation 
is illustrated by carrying out translation searches of the 
model at the correct orientation without and with PC 
refinement. Without PC refinement, hese searches gave 
high values of the correlation coefficient of 0.239 and 
0.253 for 15.0-4.0 and 8.0-5.0,~ data, respectively, at 
the correct position. The corresponding ratios to the top 
noise peaks were 1.45 and 1.18. After ten steps of PC 
refinement, he correlation coefficient dropped to 0.170 
and the ratio to the top error peak was reduced to 1.20 
for 15.0-4.0,~, data. For 8.0-5.0A data, not one of the 
top 50 peaks of the translation function corresponded to
the correct position. 
3.4. Incorporation of known structural information in 
molecular eplacement 
Subtracting the contribution of thrombin 1 from the 
structure factors as described in Methods substantially 
improves the PC refinement and the signal-to-noise 
ratios in the molecular-replacement calculations (Table 
2). For the rotation function, the peak corresponding to
thrombin 2 ranked significantly higher in the list of the 
selected peaks for all modifications as compared to the 
unmodified structure factors in the order 
(IV) > (III) > (II) > (I). The signal-to-noise ratio 
improved only with modifications (III) and (IV) and 
only in the latter was the correct peak the highest in the 
list. 
The correct orientation for thrombin 2 was the top 
peak in the PC refinement for modifications (III) and 
(IV) with (IV) having the highest signal-to-noise ratio. 
For modification (II), the peak corresponding to 
thrombin 2 was one of the three top peaks in the list, 
all with equal correlation coefficient. For modification 
(I), the signal-to-noise ratio did not improve as 
compared to the unmodified structure factors but the 
improvement in position from 17th to 6th meant here 
were fewer error peaks to be examined. It is especially 
cogent that PC refinement with all four modifications 
brought hrombin 2 very close to the correct orientation, 
differing only by 1.2 to 2.3 ° (3 in Table 2) because the 
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improvement allowed the translation-function calcula- 
tions to succeed. 
Because the orientations were so accurate after PC 
refinement, the translation searches, which failed 
abysmally for the unmodified structure factors, 
succeeded for all modifications. The correct placement 
corresponded to the top peak in all searches with a high 
signal-to-noise ratio ranging from 1.29 to 1.47. There 
appears to be no correlation between the signal-to-noise 
ratio and the specific modification. In summary, all four 
modifications of the structure factors substantially 
improve the results of the molecular-replacement 
calculations with modification (IV) _~ (III) > (II) > (I). 
The more the structure factors depend on the unknown 
molecule, the more effective the modification. 
Zhang & Matthews (1994) recently incorporated 
known structural information in the rotation and 
translation functions using 'addition' and 'subtraction' 
strategies. With 'addition' strategy the structure factors 
of the known part of the structure are added to those of 
the search model. This procedure is most effective in 
the context of the translation function because it brings 
the structure factors calculated from the search model 
closer to those observed. With the 'subtraction' 
strategy, the Patterson function of the known 
component is subtracted from the 'observed' Patterson. 
This approach is found to be most effective in the 
context of the rotation function because it eliminates 
peaks that are irrelevant o the desired solution. Our 
approach to the problem, which was developed 
independently of theirs, is conceptually similar to their 
'subtraction' strategy but computationally distinct, 
involving modifications of the structure factors external 
to the molecular-replacement programs as compared to 
modifying the rotation and translation functions, and 
can be used in conjunction with any of the available 
molecular-replacement packages without modifications 
to the programs. The results are similar to those 
obtained with the modified rotation function 
incorporating subtraction strategy, namely, a marked 
improvement in the rotational error as well as in the 
significance of the solution. 
3.5. Structure of  the complexes 
The final model consists of residues 1 H to 247 of 
both thrombin molecules with two sequential N-acetyl- 
glucosamines linked at Asn60G of thrombin 1, one 
N-acetylglucosamine linked at Asn60G of thrombin 2 
and the two peptides. Except for a few residues, the two 
thrombin molecules are well defined in the electron- 
density maps for residues 1C-14K of the A chain and 
residues 16-243 of the B chain. Crystals of bovine 
thrombin commonly incorporate both ot-thrombin and a 
proteolytic derivative, e-thrombin, which is cleaved in 
the y-autolysis loop (residues 145-150) at Thr149A 
(Martin et al., 1992). This loop contains the eponymous 
human y-thrombin cleavage site at Lys149E that is a 
glutamate residue in bovine thrombin and thus not 
cleaved. In complex 1, the electron density for this 
mobile loop is present at 0.9or except for the amide N 
atom of VaI149C in the main chain and some atoms in 
the side chains of Trp148, Thr149A and VaI149C. In 
complex 2, the main-chain density for residues Glu146- 
Thr149A is continuous, as is the density for Ser149B 
through Glu149E, but the C a atoms of Thr149A and 
Ser149B are 21 A apart. These observations imply that 
thrombin 1 is primarily cr-thrombin and thrombin 2 is 
primarily e-thrombin. 
The first 11 residues of peptide 1 bound to 
tr-thrombin, namely His51h-Glu61h, have reasonable 
electron density although His51 h and Gly54h have some 
atoms out of density. The final four carboxyl-terminal 
residues are less certain, with Tyr63h being the only 
residue with reasonable density for all main-chain and 
side-chain atoms. Peptide 2 is bound nmch less securely 
to e-thrombin than is peptide 1 to a-thrombin. Five of 
the first seven residues in peptide 2, namely His51h, 
Asn52h, and Asp55h-Glu57h ave reasonable density 
but the remaining eight carboxyl-terminal residues, 
Glu58h-Gln65h, are effectively disordered with con- 
tinuous density only for Glu62h, which has crystal 
packing contacts, and Tyr63h. 
The two complexes, which were restrained to be 
similar during refinement, have an r.m.s, difference of 
0.18A between corresponding Ca atoms. They are 
related by an overall rotation of 172.8 ° (Fig. 4). 
Compared to the bovine cr-thrombin-hirudin complex, 
the r.m.s, deviations in Ca positions are 0.56A 
for complex 1 and 0.59 A from complex 2. Compared to 
the human ot-thrombin-hirugen structure, the 
corresponding r.m.s, deviations are 0.46 and 0.48 ,h,. 
Because residues Pro186-Arg187 of thrombin 1 and 
residues Lys185-Arg187 of thrombin 2 are involved in 
intermolecular interactions, Gly186A-Gly186C in 
complex 1 and Gly186C ih complex 2 differ from 
bovine thrombin-hirudin by 1.1-1.9A. Also, in both 
complexes, Gly186C shows the largest deviations from 
the human thrombin-hirugen structure (2.0,~). 
Both peptides bind to their corresponding throm- 
bins in the fibrinogen exosite, between two surface 
loops formed by residues Lys70-Phe80 on one side 
and Phe34-Leu41 On the other, as the corresponding 
segments do in the hirudin-thrombin complexes 
(Rydel et al., 1990, 1991; Griitter et al., 1990; 
Vitali et al., 1992) and in other thrombin-inhibitor 
complexes containing hirudin C-terminal peptide 
fragments (Skrzypczak-Jankun et al., 1991; Qiu et 
al. , 1992; Maryanoff et al. , 1993; Wu et al. , 1993; 
Zdanov et al., 1993; Priestle et al., 1993; Stubbs et 
al., 1992; Banner & Hadvary, 1991). The total 
solvent-accessible surface area buried in the inter- 
action between residues 51h-65h of the peptide and 
thrombin is 1667,~ 2 in complex 1 and 1689,~ 2 in 
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complex 2, which is slightly less than one half of 
the surface area buried in the interaction between 
intact hirudin and bovine thrombin (Vitali et al., 
1992). Because of the reduced interaction surface, 
the K i for carboxyl-terminal peptides of hirudin is in 
the micromolar ange (Maraganore t al., 1990) as 
opposed to the picomolar range for hirudin. 
At physiological ionic strengths, the match of the 
negatively charged carboxyl terminus of hirudin to the 
positively charged exosite of thrombin drives the 
formation of this initial complex between the two 
regions (reviewed by Stone, Betz, Parry, Jackman & 
Hofsteenge, 1993). In the structures determined here, 
complex 1 (Fig. 2b) is stabilized by three hydrogen 
bonds and four salt bridges, of which three involve a 
symmetry-related thrombin molecule, while complex 2 
(Fig. 3b) is stabilized by just three hydrogen bonds 
(Table 3). 
The electrostatic nteractions of the two peptides with 
thrombin have some similarities but also differ from 
each other, from bovine thrombin-hirudin (Vitali et al.,  
1992) and from human thrombin-hirugen (Skrzypczak- 
Jankun et al., 1991). Both complexes have the hydrogen 
bond between the amide of Glu57h and the carbonyl O 
atom of Thr74 that is conserved among all the hirudin- 
hirugen complexes (Figs. 2b and 3b). The two 
complexes also have a hydrogen bond between the 
side-chain OE1 of Glu57h and the amide of Tyr76 that 
is more weakly conserved. It is present in bovine 
thrombin-hirudin asa 'long' hydrogen bond but absent 
in human thrombin-hirugen. 
The side chain of Glu57h also exemplifies the 
differences among the structures. In complex 1, the 
OE2 atom forms salt bridges with Arg75 and Arg175' in 
a symmetry-related complex; in complex 2 it forms a 
hydrogen bond to the amide of Tyr76; and in human 
thrombin-hirugen it makes a salt link with Arg75' in a 
symmetry-related complex. In bovine thrombin-hirudin 
Glu57h OE2 has no partner but instead the OE1 atom 
makes a salt bridge with Arg75 as well as the conserved 
hydrogen bond mentioned above with Tyr76. Another 
striking example involves the side chain of Gln38 which 
forms a hydrogen bond to the carbonyl O atom of 
Phe56h in complex 1 but has no interactions in complex 
2. It is hydrogen bonded to the amide of Phe56h in 
bovine thrombin-hirudin and to the carbonyl O atom of 
Phe57h in human thrombin-hirugen. These and other 
observed" differences among the various hirudin and 
hirudin peptide complexes are consistent with the 
conclusion that there is some flexibility in the binding 
of the C-terminal peptide of hirudin to thrombin (Vitali 
et al., 1992) and with the idea that the function of the 
charged residues is to facilitate long-range alignment of 
the molecules and not for specific short-range inter- 
actions (Karshikov, Bode, Tulinsky & Stone, 1992). 
Mutagenesis has identified Glu57h in hirudin as the 
most important charged residue for binding thrombin, 
although Asp55h, Glu58h, Glu61h and Glu62h all 
/ .  
Fig. 4. A stereoview of the C,, 
backbone of the two complexes 
looking down the approximate 
twofold axis that relates them. 
Complex 2is on top of the figure. 
Thick lines are used for the 
peptides, thin lines for thrombin. 
The non-crystallographic rotation 
axis has spherical polar angles 
~k = 69.0°; ¢o'= 85.3 °. 
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Table 3. Electrostatic interactions between hirudin51_65 and bovine thrombin 
Complex 1 
Residue Interaction Type (A) 
Phe56h O+--Gin38 NE2 Hydrogen bond 3.0 
Glu57h N---~Thr74 O Hydrogen bond 3.4 
OE1 +--Tyr76 N Hydrogen bond 3.4 
OE2+-Tyr76 N Hydrogen bond 
OE2~--Arg75 NH2 Ion pair/Hydrogen bond 3.3 
OE2 ~---Arg 175' NH 1 Ion pair/Hydrogen bond 2.9 
Glu58h OE 1 ~---Arg 175' NH 1 Ion pair/Hydrogen bond 3.3 
Glu61h OE1 +--Argl01' NH1 Ion pair 3.7 
* The angle at the acceptor atom, which lies between 70-90 °, is strained. 
Complex 2 
(A) 
3.1 
3.5* 
3.2. 
contribute (Stone, Betz, Parry, Jackman & Hofsteenge, 
1993; Yue et al., 1992). The interactions observed 
in the present structure agree with these results 
in that Glu57h forms hydrogen bonds and salt 
bridges with thrombin in complex 1 (Fig. 2) and 
hydrogen bonds in complex 2 (Fig. 3) whereas Glu58h, 
Glu61h and Glu62h do not interact directly with the 
thrombin molecule in either complex. As fit best to the 
electron density, Asp55h in complex 1 does not interact 
with thrombin although there is some density for an 
alternate position of the side chain that could salt bridge 
with Arg73. In complex 2 Asp55h makes a weak salt 
link with Arg73 (4.3 A). In bovine thrombin-hirudin, 
Asp55h has two weak salt links to Arg73 while in 
human thrombin-hirugen it forms two strong salt links. 
Similar observations in other thrombin-hirudin com- 
plexes have prompted the suggestion that the non- 
interacting acidic residues of the hirudin peptide 
contribute indirectly through a favourable interaction 
with a strong positive electrostatic field at the thrombin 
exosite (Karshikov et al., 1992). 
The existence of the electrostatic interactions in the 
complexes under discussion (Table 3) is remarkable, 
given that they are crystallized at 1.6M ammonium 
sulfate. By contrast, bovine thrombin-hirudin (Vitali et 
al., 1992) and human thrombin-hirugen (Skrzypczak- 
Jankun et al., 1991) were crystallized from approxi- 
mately 0.35 and 0.43M salt, respectively, using 
polyethylene glycol as the precipitant. At zero ionic 
strength, approximately 1/3 of the free energy of 
binding of hirudin to thrombin is electrostatic 
(Karshikov et al., 1992); the electrostatic free energy 
is halved when the ionic strength is increased to 0.125 M 
while the contribution from other sources, such as van 
der Waals contacts and hydrophobic exclusion, remains 
unchanged (Karshikov et al., 1992). More generally, 
others have argued that surface salt bridges are not 
stable at physiological ionic strength because the energy 
gained in a salt link is approximately equal to the 
entropy lost when the side chains are restrained (Sali, 
Bycroft & Fersht, 1991; Dao-Pin, Sauer, Nicholson & 
Matthews, 1991). Consequently, stable surface links 
require supplemental interactions that overcome the 
entropy cost by fixing the residues near one another. 
Here, the hydrophobic free energy, particularly from 
Phe56h, Ile59h, Pro60h, and Tyr63h in complex 1 and 
Phe56h and Tyr63h in complex 2 anchors the peptide 
chain, thereby fostering the electrostatic nteractions. 
The importance of the hydrophobic residues, Phe56h, 
Ile59h and Tyr63h, in the formation of the thrombin- 
hirudin complex has been shown by mutagenesis (Stone 
et al., 1993; Yue et al., 1992). In both complexes 
reported here, the side chain of Phe56h is sandwiched 
between the ring of Phe34 and Thr74, making close 
contacts with Phe34, Thr74 and Leu40 (Figs. 2 and 3). 
The stacking of the phenylalanine rings has the 
characteristic edge-on pattern (Burley & Petsko, 
1985). In complex 1, Ile59h, Pro60h and Tyr63h 
make close contacts with Leu65, Tyr76, and with 
Leu65 and I1e82 of thrombin, respectively, and with 
each other, while Tyr63h in complex 2 makes close 
contacts with Leu65 and Met84. Similar hydrophobic 
interactions are present in the bovine thrombin-hirudin 
complex (Vitali et al., 1992) and in the human throm- 
bin-hirugen complex (Skrzypczak-Jankun et al., 1991). 
Peptide 1 is better defined than peptide 2 because it 
has many more electrostatic nteractions with thrombin, 
including some ion pairs that involve crystal packing 
contacts (Table 3). However, the greater disorder of 
peptide 2 is at least partly related to the cleavage at 
Thr149A in e-thrombin, as evidenced by its lower 
affinity for hirudin compared to a-thrombin in solution 
(Stone, Braun & Hofsteenge, 1987). In complex 1, 
Thr149A and Ser149B in the intact ),-autolysis loop are 
within 3.5 ,~, of peptide 1 and can potentially form 
hydrogen bonds with Asn52h and Asp53h, respectively. 
In complex 2 the two parts of the severed loop in e- 
thrombin have moved away from the peptide in the 
exosite. This movement breaks any direct interactions, 
and should also perturb the electrostatic field. 
These observations are also germane to the fact that 
hirudin (Dodt et al., 1988, 1990), and hirudin-related 
carboxyl-terminal fragments (Maraganore t al., 1989; 
DiMaio et al., 1990) bind more tightly to human than to 
bovine ct-thrombin because of species differences in the 
interaction at the exosite (Dodt et al., 1990). Human 
thrombin has alanine replacing Thr149A and asparagine 
replacing Ser149B. Previously, the only established 
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difference occurred at position 149E, which is a lysine 
in human thrombin and a glutamate in bovine thrombin. 
In human thrombin, Lys149E contributes to the positive 
electrostatic field at the exosite and forms an ion pair 
with Asp55h in the complex with hirudin (Rydel et al., 
1991). In bovine thrombin, Glu149E can do neither 
(Vitali et al., 1992). The y-autolysis loop, which is very 
mobile, has different conformations in different hrom- 
bin structures and is usually ordered only if stabilized 
by crystal contacts (Vijayalakshmi, Padmanabhan, 
Mann & Tulinsky, 1994). Thus, the conformation of 
the y-autolysis loop in complex 1 is not unique but does 
suggest how the loop could interact with exosite ligands 
in solution. 
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